Physician profile
Darren E Elg
NPI 1437149069
$1,099.77
in general payments reported to CMS, 2019-2025
15 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $49.81 · 2021: $221 · 2022: $315 · 2023: $75.26 · 2024: $98.90 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $377.01 | 2019-2025 | Precision7, Precision 7, Dailies Total1 |
| Bausch & Lomb Americas INC. | $160.50 | 2022-2023 | Biotrue One Day |
| Johnson & Johnson Vision Care, INC. | $147.54 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $94.91 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $75.81 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $53.22 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $36.26 | 2022 | |
| Abbvie INC. | $31.47 | 2022-2023 | |
| Coopervision INC. | $26.56 | 2022 | |
| Oyster Point Pharma, INC. | $23.42 | 2022 | |
| Allergan, INC. | $15.74 | 2021 | |
| Sun Pharmaceutical Industries INC. | $15.58 | 2019 | |
| Visioneering Technologies, INC. | $14.57 | 2019 | |
| Shire North American Group INC | $13.81 | 2019 | |
| Optos, INC. | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Elg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.